Clinical Trials in Tennessee

Showing 6881-6900 of 15,329 trials

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

NCT05061940

The purpose of this study is to obtain archived tumor tissue or pre-existing antigen expression data from patients with Head and Neck, Cervical, Melanoma and Non-Small Cell Lung Cancers to assess antigen expression and patient suitability for a Repertoire Immune Medicines Treatment Protocol.

Head and Neck CancerMelanomaHPV-Related Malignancy+5 more

Repertoire Immune Medicines22 participantsStarted May 2021

Scottsdale, Arizona, United States • Ann Arbor, Michigan, United States • Nashville, Tennessee, United States

COMPLETEDPhase 1/229 miles

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

NCT00062816

The purposes of this Phase 1/2 study are to examine the safety, tolerability, and antiviral activity of ISIS 14803, when given in combination with peginterferon alfa and ribavirin, to patients who either failed to have at least a 100-fold HCV reduction at Week 12 of standard therapy or still have detectable HCV at Week 24.

Hepatitis C, Chronic

Ionis Pharmaceuticals, Inc.22 participantsStarted Jun 2003

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Orange, California, United States +22 more locations

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Find Trials by Condition in Tennessee

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

CD36 in Nutrient Delivery and Its Dysfunction

PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

SMART Optimization of a Parenting Program for Active-duty Families

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Negative Pressure Wound Therapy to Reduce Surgical Site Infection

Vitala 12 Hour Wear Test With Convex Products

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

A Clinical Trial of PRAX-114 in Participants With Essential Tremor

The International Diabetes Closed Loop (iDCL) Trial: Protocol 4

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory